Capital Advisory Group Advisory Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,204
Closed -$282K 283
2022
Q1
$282K Sell
2,204
-68
-3% -$7.44K 0.13% 128
2021
Q4
$305K Buy
2,272
+8
+0.4% +$1.15K 0.13% 127
2021
Q3
$310K Sell
2,264
-4
-0.2% -$504 0.11% 152
2021
Q2
$242K Sell
2,268
-156
-6% -$15K 0.09% 178
2021
Q1
$218K Buy
2,424
+80
+3% +$7.51K 0.08% 176
2020
Q4
$217K Buy
2,344
+2,304
+5,760% +$206K 0.09% 173
2020
Q3
$4K Buy
+40
New +$4.18K ﹤0.01% 396

Other funds holding DXCM

Capital Advisory Group Advisory Services's DXCM Position: Q2 2022 in Review

Capital Advisory Group Advisory Services sold out of DexCom (DXCM) in Q2 2022, closing a stake of 2,204 shares — an estimated $282K sold.

Capital Advisory Group Advisory Services first reported a position in DXCM in Q3 2020 and held it in 7 quarters. The position peaked at $310K in Q3 2021. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Capital Advisory Group Advisory Services reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Capital Advisory Group Advisory Services sold 2,204 DexCom shares in Q2 2022, an estimated $282K.
  • Capital Advisory Group Advisory Services first reported a position in DexCom in Q3 2020 and held it in 7 quarters.
  • Capital Advisory Group Advisory Services's DexCom position peaked at $310K in Q3 2021.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.